secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K
Filed at:   2026-03-20T23:59:59+00:00
Accession:  0001683168-26-002064
Event type: regulatory
Sentiment:  negative
Materiality: 0.55
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Tivic Health receives Nasdaq bid price deficiency notice; 180 days to regain compliance
--------------------------------------------------------------------------------

- Received Nasdaq notification on March 19, 2026 for bid price below $1.00 for 30 consecutive business days.
- Compliance period ends September 15, 2026; must have closing bid ≥$1.00 for 10 consecutive days.
- If not compliant by Sept 15, may qualify for second 180-day period if other listing standards met.
- Stock remains listed on Nasdaq Capital Market with no immediate effect on trading.
- Company will monitor and consider available options to resolve the deficiency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000168316826002064/0001683168-26-002064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000168316826002064/tivic_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-002064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer